Seattle Genetics, Inc. (NASDAQ:SGEN) announced that it has initiated an open-label, multi-center, dose-escalation phase Ib study on SGN-CD33A for the treatment of patients with newly diagnosed acute myeloid leukemia (AML). Seattle Genetics Inc. (NASDAQ:SGEN) in last trading activity fell -0.73% to close at $32.65. Company weekly performance is 3.95% while its quarterly performance stands at -18.60%. Seattle Genetics Inc. (NASDAQ:SGEN) is -41.69% away from its 52 week high.
Hemispherx Biopharma, Inc. (NYSE MKT:HEB) announced on 16 December further progress on developing Ampligen® (rintatolimod) as a potential therapeutic complement to a new molecular class of anti-tumor drugs termed immune checkpoint inhibitors or PD-1 inhibitors (also called Programmed Death inhibitors). On last trading day Hemispherx Biopharma, Inc. (NYSEMKT:HEB) remains unchanged to close at $0.24. Its volatility for the week is 6.34% while volatility for the month is 5.97%. HEB’s sales growth for past 5 years was -7.80% and its EPS growth for past 5 years was 9.00%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) monthly performance is -11.11%.
The Board of Directors of SkyWest, Inc. (NASDAQ:SKYW) said it has declared a quarterly dividend of USD0.04 per share to shareholders of record at the close of business on December 31, 2014 on all shares then issued and outstanding. On last trading day SkyWest Inc. (NASDAQ:SKYW) advanced 2.19% to close at $12.15. Its volatility for the week is 4.46% while volatility for the month is 3.89%. SKYW’s sales growth for past 5 years was -1.20% and its EPS growth for past 5 years was -10.30%. SkyWest Inc. (NASDAQ:SKYW) monthly performance is 2.45%.
TransAtlantic Petroleum Ltd. (NYSEMKT:TAT) announced that it expects to issue between $25.0 and $55.0 million of convertible notes in a private placement. If $55.0 million of notes are issued, the notes will not be convertible into more than 19.9% of the Company’s currently outstanding common shares. TransAtlantic Petroleum Ltd. (NYSEMKT:TAT) has 1.50% insider ownership while its institutional ownership stands at 20.30%. In last trading activity company’s stock closed at $5.70.
Boyd Gaming Corporation (NYSE:BYD) VP Brian A. Larson sold 16,071 shares of the stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $12.33, for a total value of $198,155.43.On Monday shares of Boyd Gaming Corporation (NYSE:BYD) closed at $11.89. Company’s sales growth for last 5 years was 10.20%.